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Scientific Abstracts gastrointestinal involvement (GI), nutritional status and medications may lead to Vit B12 deficiency. Objectives: We aimed to investigate the frequency of Vit B12 deficiency and its determinants in SSc patients. Methods: Sixty-two (90.3% female) SSc patients were enrolled in to the study. The nutritional status of patients was assessed with Malnutrition Universal Screening Tool (MUST). Serum Vitamin B12, homocysteine and Helicobacter Pylori Immunoglobulin G (H. Pylori IgG) levels were measured in all patients. Serum Vit B12 levels of patients were classified as; Low (<200 pg/ml), Borderline (200 -300 pg/ml) and Normal (>300 pg/ml). Serum homocysteine levels of patients were classified as; Elevated (>9 μmol/L) and hyperhomocysteinemia (>15 μmol/L). H. Pylori IgG antibody level >5 U/ml considered as positive. Serum Vit B12 level <200 pg/ml or being on Vit B12 replacement therapy was considered as B12 deficiency.
Results: The mean age of the patients was 50.2 (12.5) years and mean disease duration was 12.0 (7.5) years. Forty-four (71.0%) patients were limited and 18 (29.0%) patients had diffuse SSc. The mean serum Vit B12 level of the patients was 323.6±291.5 pg/ml. Seventeen (27.4%) patients had normal, 23 (37.1%) patients had borderline and 22 (35.5%) patients had low serum Vit B12 level. Forty-four (71.0%) patients were considered as Vit B12 deficient; 22 had serum Vit B12 level <200 pg/ml (4 of these patients were on vitamin B12 replacement therapy), 22 were already on Vit B12 replacement therapy and Vit B12 level ≥200 pg/ml. The mean homocysteine levels were higher in the group with Vit B12 <200 pg/ml as compared to other groups (p=0.005). In the group with Vit B12 level <200 pg/ml, 33.3% (7/21) of the patients had hyperhomocysteinemia and 76.2% (16/21) had 'elevated homocysteine levels ( Background: Involvement of skin and musculoskeletal system in systemic sclerosis (SSc) leads to loss of function, disability and reduced quality of life. Data on efficacy of non-pharmacologic care in SSc is very limited due to variety in studied interventions/outcomes. Objectives: To address the limitations of existing studies, and evaluate the effect of a controlled, long-term (24-week intervention, 24-week follow-up), intensive (1h physiotherapy + 0.5h occupational therapy twice weekly, and home-exercise for 0.5h 5x weekly), tailored physiotherapy programme on function/impairment of hands/face, and quality of life/disability in cohorts with a substantial number of SSc patients. Methods: All patients fulfilled ACR/EULAR 2013 criteria, had skin involvement of hands/mouth, and were consecutively recruited from 2014 to 2016 at the Institute of Rheumatology in Prague. Both groups received educational materials and instructions for home exercise at baseline, however, only intervention group underwent the intensive physiotherapy programme. At months 0,3,6,12 all patients were assessed by a physician (physical examination, mRSS-Modified Rodnan's skin score, EUSTAR SSc activity score, Medsger SSc severity score), and a physiotherapist blinded to intervention [validated measurements (dFTPdelta finger to palm, inter-incisor/inter-lip distance, grip strength using Baseline dynamometer); tests (HAMIS-Hand Mobility In Scleroderma)], patients filled out patient reported outcomes/questionnaires (CHFS-Cochin Hand Function Scale, MHISS-Mouth Handicap In SSc Scale, HAQ, SHAQ, SF-36) and provided blood for routine laboratory analysis and biobanking. Normality of data was tested, inter-group analysis was performed with 2-way ANOVA, and intra-group analysis by Friedmann's test with Dunn's post hoc test. Results: 25 SSc patients (22 female/3 male, 14 limited cutaneous (lc)SSc/11 diffuse cutaneous (dc)SSc, median of age 54.0 and disease duration 7.0 years, mRSS 12) were recruited into the intervention group (IG) and 29 patients into the control group (CG) (25 female/4 male, 16 lcSSc/13 dcSSc, median of age 49.0 and disease duration 5.0 years, mRSS 11). Compared to observed statistically significant deterioration in CG over the period of m0-m6, we found statistically significant improvement in dFTP, grip strength, HAMIS, inter-incisor and inter-lip
